Phaeochromocytoma and paraganglioma

Area of Science:

• Endocrinology
• Oncology
• Neuroscience

Background:

• Phaeochromocytomas and paragangliomas are rare neuroendocrine tumors derived from chromaffin cells.
• These tumors produce excess catecholamines, leading to severe, potentially fatal, hypertensive crises.
• Early detection and management are crucial for improving patient outcomes.

Purpose of the Study:

• To provide a comprehensive overview of phaeochromocytomas and paragangliomas.
• To outline best practices for screening, diagnosis, and management.
• To emphasize the importance of familial risk assessment.

Main Methods:

• Review of current literature and clinical guidelines.
• Synthesis of diagnostic criteria and imaging techniques.
• Discussion of pharmacological and surgical treatment strategies.

Main Results:

• Catecholamine-producing tumors present with diverse symptoms, including hypertension, palpitations, and sweating.
• Diagnostic workup involves biochemical tests (metanephrines) and imaging (CT, MRI, MIBG scan).
• Management requires a multidisciplinary approach, often involving tumor resection and lifelong surveillance.

Conclusions:

• Prompt diagnosis and appropriate management of phaeochromocytomas and paragangliomas can prevent life-threatening complications.
• Genetic screening is essential for identifying hereditary syndromes and at-risk family members.
• Adherence to best practice guidelines improves patient survival and quality of life.